节点文献

SDF-1在大鼠颞下颌关节骨关节炎相关性的研究

Studies on the correlation between SDF-1 and temporomandibular joint osteoarthrits in rats

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈言王晓燕姜林宏汲平

【Author】 CHEN Yan;WANG Xiao-yan;JIANG Lin-hong;JI Ping;Department of Prosthodontics, School of Stomatology, Shandong University,Shandong Provincial Key Laboratory of Oral Biomedicine;

【机构】 山东大学口腔医学院修复科山东省口腔组织再生重点实验室山东大学口腔医学院修复科山东省组织再生医学重点实验室

【摘要】 目的:观察SDF-1在大鼠颞下颌关节骨关节炎中的表达以及其与MMP-13、IL-1β和P38MAPK的相关性。方法:48只wistar大鼠随机分为对照组、模型组、高浓度抑制剂组和低浓度抑制剂组,采用关节腔注射碘乙酸钠溶液建立大鼠TMJOA模型。抑制剂组大鼠在建模后分别注射0.1μg/μL及1μg/μL SDF-1/CXCR4信号轴抑制剂AMD3100。后处死各组大鼠,取双侧颞下颌关节组织进行HE染色、番红固绿染色(S.O)以评价关节炎症水平;通过RT-PCR及免疫组化检测MMP-13、IL-1β的表达量;通过免疫组化染色检测p38MAPK。结果:对照组、高浓度抑制剂组、低浓度抑制剂组及模型组组织评分为:0.75±0.43、5±0.71、8±0.71、11.5±0.5。p-p38表达量为:(14.3±2.2)%、(41.5±2.2)%、(60.0±3.8)%、(74.9±3.5)%。IL-1β表达量为(12.8±1.0)%、(40.1±2.3)%、(64.2±4.4)%、(81.2±3.5)%;IL-1βm RNA为0.97±0.11、3.38±0.48、5.03±0.23、6.35±0.35。MMP-13表达量为(13.2±1.2)%、(38.2±2.3)%、(62.1±3.3)%、(80.9±3.0)%;MMP-13m RNA为0.96±0.18、2.54±0.41、5.24±0.45、6.31±0.35。对照组及模型组中SDF-1表达量为(26.1±3.2)%、(75.2±4.5)%;SDF-1m RNA为1.02±0.14、6.26±0.45。结果表明,随抑制剂剂量增加,关节炎症水平明显降低,MMP-13、IL-1β、p38MAPK表达量显著下调(P<0.05)。结论:SDF-1在颞下颌关节骨关节病的作用与促进MMP-13及IL-1β的表达和p38MAPK通路的激活相关。

【Abstract】 Objective: To investigate the effect of SDF-1 on expression of IL-1βMMP13 and P38 MAPK in rat temporomandibular joint osteoarthritis(TMJOA). Method:48 wistar rats were allocated to the control group,the pathologic model group or the antagonist groups. TMJOA was induce by injection of monosodium iodoacetate(MIA) into the upper compartment of bilateral TMJs of rats. SDF-1/CXCR4 axis antagonist AMD3100 were injected into the upper compartment of bilateral TMJs of rats in the antagonist groups after the pathologic model was established. Then all rats were sacrii ced. HE and Safranin O-fast green(S.O) staining were performed to evaluate the severity of TMJOA. The expressions of MMP-13,IL-1βwere detected by RT-PCR and Immunohistochemistry and the level of p38 MAPK were tested by Immunohistochemistry. Result: The pathological scores of control group,high or low antagonist concentration groups and pathologic model group were 0.75±0.43,5±0.71,8±0.71,11.5±0.5. The expression of p-p38 were(14.3±2.2)%,(41.5±2.2)%,(60.0±3.8)%,(74.9±3.5)%. The expression of IL-1β were(12.8±1.0)%,(40.1±2.3)%,(64.2±4.4)%,(81.2±3.5)%. The expression of IL-1βm RNA were 0.97±0.11,3.38±0.48,5.03±0.23,6.35±0.35. The expression of MMP-13 were(13.2±1.2)%,(38.2±2.3)%,(62.1±3.3)%,(80.9±3.0)%. The expression of MMP-13 m RNA were 0.96±0.18,2.54±0.41,5.24±0.45,6.31±0.35. The expression of SDF-1 in control group and pathologic model group were(26.1±3.2)%,(75.2±4.5)%. The expression of SDF-1m RNA were 1.02±0.14,6.26±0.45. Results shows with the increasing amount of antagonist applied, the severity of TMJOA and the expressions of MMP-13,IL-1βand p38 MAPK were significantly reduced.Conclusions: The pathological ef ect of SDF-1 on TMJOA is correlated with the increasing expression of MMP-13 and IL-1β and the activation of p38 MAPK.

【基金】 山东省科技发展计划(项目编号:2014GSF118027)
  • 【文献出处】 口腔颌面修复学杂志 ,Chinese Journal of Prosthodontics , 编辑部邮箱 ,2017年01期
  • 【分类号】R782.6
  • 【被引频次】4
  • 【下载频次】173
节点文献中: 

本文链接的文献网络图示:

本文的引文网络